Brandywine Managers, LLC
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 15, 2025), Brandywine Managers, LLC reported 35 stock positions worth $83.4 million. Its top holding was iShares MSCI Acwi ETF (ACWI) at 41.0% of the portfolio, followed by CrowdStrike Class A (CRWD, 13.9%) and Uipath Class A (PATH, 12.5%). Compared with Q4 2024, it sold out of 2, added to 2 and reduced 6. The biggest buy was 10X Genomics Class A (TXG, shares +88%) and the biggest sale iShares MSCI Acwi ETF (ACWI, shares −15%).
- Most Recent 13F
- Q2 2026
- Location
- HOCKESSIN, DE
- CIK
- 0001135121
- Portfolio Value
- $83.4M (Q1 2025)
- SEC Filing
- 0000919574-25-003035 ↗ filed May 15, 2025
Holdings Value
Holdings 35 stocks · $83.4M
| ACWI iShares MSCI Acwi ETF | 41.01% | 293,679 | $34.2M | Reduce -15.0% |
| CRWD CrowdStrike Holdings Inc. Class A | 13.88% | 32,814 | $11.6M | No change |
| PATH Uipath Inc. Class A | 12.48% | 1,009,684 | $10.4M | No change |
| NTRA Natera Inc. | 3.06% | 18,038 | $2.6M | Reduce -1.6% |
| NVDA Nvidia Corp. | 2.64% | 20,310 | $2.2M | Reduce -5.0% |
| UBER Uber Technologies Inc. | 2.57% | 29,354 | $2.1M | No change |
| CRM Salesforce Inc. | 2.23% | 6,913 | $1.9M | No change |
| ZS Zscaler Inc. | 1.99% | 8,359 | $1.7M | No change |
| ISRG Intuitive Surgical Inc. | 1.93% | 3,243 | $1.6M | Reduce -2.7% |
| IOT Samsara Inc. Class A | 1.42% | 30,970 | $1.2M | No change |
| ALNY Alnylam Pharmaceuticals Inc. | 1.41% | 4,348 | $1.2M | No change |
| OKTA Okta Inc. | 1.40% | 11,109 | $1.2M | Reduce -12.4% |
| NET Cloudflare Inc. Class A | 1.34% | 9,906 | $1.1M | No change |
| DDOG Datadog Inc. Class A | 1.20% | 10,100 | $1.0M | No change |
| MA Mastercard Inc. Class A | 1.17% | 1,785 | $978K | No change |
| TWST Twist Bioscience Corp. | 0.99% | 20,970 | $823K | No change |
| AMD Advanced Micro Devices | 0.97% | 7,898 | $811K | No change |
| VEEV Veeva Systems Inc. Class A | 0.91% | 3,259 | $755K | Reduce -16.8% |
| SNOW Snowflake Inc. | 0.87% | 4,988 | $729K | No change |
| NOW ServiceNow Inc. | 0.85% | 893 | $711K | No change |
| MDB Mongodb Inc. | 0.74% | 3,501 | $614K | Add +22.5% |
| LLY Eli Lilly & Co. | 0.69% | 697 | $576K | No change |
| PD Pagerduty Inc. | 0.67% | 30,517 | $558K | No change |
| GH Guardant Health Inc. | 0.52% | 10,233 | $436K | No change |
| SDGR Schrodinger Inc. | 0.49% | 20,886 | $412K | No change |
| S Sentinelone Inc. Class A | 0.41% | 19,001 | $345K | No change |
| NVO Novo-Nordisk A/S-Spons ADR | 0.35% | 4,222 | $293K | No change |
| MRNA Moderna Inc. | 0.32% | 9,510 | $270K | No change |
| KVYO Klaviyo Inc. Class A | 0.32% | 8,692 | $263K | No change |
| TWLO Twilio Inc. Class A | 0.28% | 2,357 | $231K | No change |
| BEAM Beam Therapeutics Inc. | 0.26% | 11,306 | $221K | No change |
| GPCR Structure Therapeutics Inc. | 0.23% | 11,057 | $191K | No change |
| TXG 10X Genomics Inc. Class A | 0.20% | 18,938 | $165K | Add +88.0% |
| RLAY Relay Therapeutics Inc. | 0.12% | 38,429 | $101K | No change |
| ABCL Abcellera Biologics Inc. | 0.08% | 28,488 | $64K | No change |
Portfolio Sells Q4 2024 → Q1 2025
| ACWI iShares MSCI Acwi ETF | Reduce -15.0% | 41.01% | −1.79 |
| NVDA Nvidia Corp. | Reduce -5.0% | 2.64% | −0.39 |
| VKTX Viking Therapeutics Inc. | Sold out | 0.00% | −0.34 |
| MBLY Mobileye Global Inc. Class A | Sold out | 0.00% | −0.27 |
| NTRA Natera Inc. | Reduce -1.6% | 3.06% | +0.00 |
| VEEV Veeva Systems Inc. Class A | Reduce -16.8% | 0.91% | +0.04 |
| ISRG Intuitive Surgical Inc. | Reduce -2.7% | 1.93% | +0.09 |
| OKTA Okta Inc. | Reduce -12.4% | 1.40% | +0.35 |
Portfolio Buys Q4 2024 → Q1 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 46 | $202.2M | CPB, ACWI, CRWD, PATH, NTRA |
| Q1 2026 | 40 | $169.9M | CPB, ACWI, CRWD, PATH, NVDA |
| Q4 2025 | 38 | $202.3M | CPB, ACWI, PATH, CRWD, NVDA |
| Q3 2025 | 37 | $104.2M | ACWI, CRWD, PATH, NVDA, UBER |
| Q2 2025 | 36 | $100.6M | ACWI, CRWD, PATH, NVDA, NTRA |
| Q1 2025 | 35 | $83.4M | ACWI, CRWD, PATH, NTRA, NVDA |
| Q4 2024 | 37 | $94.9M | ACWI, PATH, CRWD, NTRA, NVDA |
| Q3 2024 | 35 | $93.0M | ACWI, PATH, CRWD, NVDA, NTRA |
| Q2 2024 | 36 | $94.5M | ACWI, PATH, CRWD, NVDA, UBER |
| Q1 2024 | 40 | $101.3M | ACWI, PATH, CRWD, NVDA, UBER |